Rapid Practice Points for Respiratory Syncytial Virus Vaccines in Non-Pregnant Healthy Adults - Docwire News
Rapid Practice Points for Respiratory Syncytial Virus Vaccines in Non-Pregnant Healthy Adults Docwire News
Rapid Practice Points for Respiratory Syncytial Virus Vaccines in Non-Pregnant Healthy Adults Docwire News
Is RSV contagious? Everything you need to know about this virus. UCHealth
Vaccines for Adults | RSV Centers for Disease Control and Prevention | CDC (.gov)
Respiratory syncytial virus (RSV) Infant Monoclonal Antibody Administration Extension KDHE.ks.gov
Respiratory syncytial virus (RSV) in adults: risk and vaccination Hospital Clínic Barcelona
Interactions of SARS-CoV-2, influenza and respiratory syncytial virus influence epidemic timing and risk Nature
In vitro liquid-liquid phase separation induced by respiratory syncytial virus proteins and RNA Science | AAAS
Respiratory virus vaccines: Clinical guidance and resources American Academy Of Family Physicians | AAFP
Guillain-Barré Syndrome Following Respiratory Syncytial Virus (RSV) Infection in the Third Trimester: A Case Report of a Rare Entity Cureus
CIDRAP Op-Ed: RSV—the middle child of respiratory season who deserves more attention CIDRAP
-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection Nature
Respiratory Syncytial Virus Infection American Academy Of Family Physicians | AAFP
Getting the RSV vaccine during pregnancy is a game-changer for infant hospitalizations CIDRAP
Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies Cureus
The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis Nature
Mathematical analysis of a stochastic delay model for respiratory syncytial virus dynamics Nature
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study Nature
Analysis of DNA methyltransferase 3 alpha expression during respiratory syncytial virus strain A infection Nature
Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model Nature
Whole-genome nanopore sequencing and automatic downstream analysis of respiratory syncytial virus using RSVTyper Nature
Short-term environmental changes and respiratory syncytial virus infection in Chile Nature
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV) Business Wire
Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control Wiley Online Library
RSV symptoms in older adults often linger, studies show CIDRAP
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study The Lancet
Universal Respiratory Syncytial Virus Prophylaxis Decreases Health Care Use by Infants American Academy Of Family Physicians | AAFP
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids CIDRAP
When To Take a Baby With RSV to the Hospital Cleveland Clinic Health Essentials
Respiratory syncytial virus (RSV) resources American Medical Association
Severe Respiratory Syncytial Virus Bronchiolitis Complicated by Bilateral Massive Pleural Effusions in a Previously Healthy Infant: A Case Report Cureus
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates CIDRAP
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation The Lancet
Respiratory Virus Hospitalization Surveillance Network (RESP-NET) Centers for Disease Control and Prevention | CDC (.gov)
Universal nirsevimab slashes RSV infant hospitalizations, study suggests CIDRAP
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest CIDRAP
A living systematic review and meta analysis on the efficacy and safety of respiratory syncytial virus vaccines European Centre for Disease Prevention and Control (ECDC)
RSV vaccination coverage remains low among older US adults CIDRAP
RSV tied to heart problems, breathing issues well after infection in adults CIDRAP
Respiratory syncytial virus downregulates the airway aryl hydrocarbon receptor pathway: implication for the development of a novel therapeutic target American Physiological Society Journal
Hospitalisation and healthcare burden of respiratory syncytial virus in adults over 50 years in France medRxiv